PORTAL JEMBER – The global pandemic that has a very significant impact on the lives of all human beings today has made many countries race to produce corona vaccines as soon as possible.
A number of countries through their experts, with enormous financial support, are starting to show results that give hope to the world to be immediately free of a pandemic.
Apart from China as the first country where the pandemic started, a number of other countries also contributed to immediately find a vaccine for this deadly virus.
In the midst of waiting, the international world was shocked that Russia had agreed to use the corona virus vaccine (Covid-19) in August 2020. But a number of experts said they were not surprised because Russia was moving forward quickly.
Also Read: Career and Wealth Traces of Djoko Tjandra: Pioneering from Papua, Entering Abroad
Moscow officials hope their vaccine will get approval for wide use in the next two weeks so production can take place shortly. This was revealed in an interview with The National on Friday (7/31/2020).
Vaccine development at the Gamaleya Epidemiology and Microbiology Research Institute in the Russian capital has been funded by the government-controlled Russian Direct Investment Fund.
Prof. John Oxford, one of the authors of the book Human Virology, said he was “impressed but not surprised” at how sophisticated the program was.
“This comes from the Gamaleya institute – a quite large research institute in Moscow … They will ensure that the tests are of an international standard so that they can be cross-licensed overseas as well as in Russia,” he said.
Also Read: Record First Death for Covid-19, Vietnam Alerts Entire City to Face Pandemic
Like most, Russian vaccine programs use existing vaccine technology to change new coronaviruses.
This is based on a version of the common cold virus, called adenovirus, which is genetically engineered to produce surface proteins or spike proteins from new coronaviruses. This spike protein stimulates an immune response that should protect against the corona virus.
Ian Jones, a professor of virology at the University of Reading in the United Kingdom, said the fact that Russian vaccines are based on well-understood technology means it is unlikely to pose a danger.
“Because of all the work done on vectors (adenoviruses), I think it might be safe,” he said.
In an interview with The National, the chief executive of the Russian Direct Investment Fund, Kirill Dmitriev, said he hoped the vaccine would be the first of more than 100 being developed worldwide to be approved.
Also Read: Good News: BOS Funds Can Be Used to Buy Credit for Teachers and Students’ Parents
Mr Dmitriev said the vaccine, which he himself had injected, stimulated antibody production in all those tested in phase 1 and 2 clinical trials.
The latest update of the World Health Organization – released this week – shows that there are 25 potential vaccines undergoing clinical trials, plus 139 in preclinical evaluations.
Of those already in clinical trials, only four – one American, one British and two Chinese – were listed as having reached stage 3 trials, which analyzed real-world effectiveness.